ArticleJournal of comparative effectiveness research2023

A real-world comparison of the clinical and economic utility of OVA1 and CA125 in assessing ovarian tumor malignancy risk.

Gerard P Reilly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.